SEC 13F Intelligence

Bios Capital Management, LP / LTRN

Bios Capital Management, LP’s Lantern Pharma Inc Position

Does Bios Capital Management, LP own Lantern Pharma Inc (LTRN)? Yes — 864.4K shares worth $1M (+2.24% of its 13F portfolio) as of Q1 2026, down from 1.01M shares the prior filed quarter.

Position Value
$1M
Q1 2026
Shares
864.4K
% of Portfolio
+2.24%
Quarters Held
6
currently held

Position History LTRN

Reported value by quarter
Q4 ’24: $4MQ4 ’24Q1 ’25: $4MQ1 ’25Q2 ’25: $3MQ2 ’25Q3 ’25: $4MQ3 ’25Q4 ’25: $3MQ4 ’25Q1 ’26: $1MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026864.4K$1M+2.24%
Q4 20251.01M$3M+3.70%
Q3 20251.02M$4M+4.97%
Q2 20251.08M$3M+4.68%
Q1 20251.21M$4M+5.40%
Q4 20241.21M$4M+4.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bios Capital Management, LP’s full portfolio or all institutional holders of LTRN.